Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Escalade | ESCA | Sep 20, 2024 | 13.83 | +1.32 |
Esco Technologies | ESE | Sep 20, 2024 | 125.01 | -0.30 |
ESGL | ESGL | Sep 20, 2024 | 1.88 | +2.73 |
ESH Acquisition | ESHA | Sep 20, 2024 | 10.52 | 0.00 |
Eshallgo | EHGO | Sep 20, 2024 | 2.20 | 0.00 |
Esperion Therapeutics | ESPR | Sep 20, 2024 | 1.68 | -4.00 |
Espey Mfg & Electronics | ESP | Sep 20, 2024 | 23.75 | -6.68 |
Esquire Financial | ESQ | Sep 20, 2024 | 63.09 | -2.26 |
ESS Tech | GWH | Sep 20, 2024 | 5.63 | -11.20 |
ESSA Bancorp | ESSA | Sep 20, 2024 | 18.61 | -5.44 |
ESSA Pharma | EPIX | Sep 20, 2024 | 6.46 | -0.31 |
Essent Group | ESNT | Sep 20, 2024 | 63.52 | -1.58 |
Essential Properties Realty Trust | EPRT | Sep 20, 2024 | 34.10 | +0.65 |
Essential Utilities | WTRG | Sep 20, 2024 | 38.00 | -0.84 |
Essex Property Trust | ESS | Sep 20, 2024 | 306.21 | -1.99 |
Establishment Labs | ESTA | Sep 20, 2024 | 42.45 | -3.43 |
Estee Lauder Companies | EL | Sep 20, 2024 | 85.01 | -2.78 |
Estrella Immunopharma | ESLA | Sep 20, 2024 | 1.01 | +4.65 |
Eterna Therapeutics | ERNA | Sep 20, 2024 | 1.28 | +1.59 |
ETFMG Alternative Harvest ETF | MJ | Sep 20, 2024 | 3.25 | -2.69 |
Ethan Allen Interiors | ETD | Sep 20, 2024 | 31.84 | -1.79 |
Eton Pharmaceuticals | ETON | Sep 20, 2024 | 5.42 | -8.14 |
Etsy | ETSY | Sep 20, 2024 | 53.91 | -0.30 |
Euda Health | EUDA | Sep 20, 2024 | 3.60 | +4.96 |
Eupraxia Pharmaceuticals | EPRX | Sep 20, 2024 | 2.87 | +2.65 |
Eureka Acquisition | EURK | Sep 20, 2024 | 10.04 | 0.00 |
Eureka Acquisition | EURKU | Sep 20, 2024 | 10.22 | 0.00 |
Euro Tech Holdings | CLWT | Sep 20, 2024 | 1.64 | -2.96 |
Euro Trust | FXE | Sep 20, 2024 | 103.11 | 0.00 |
EuroDry | EDRY | Sep 20, 2024 | 20.50 | +1.76 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.